Leqi Shen 2023. HR-Positive Breast Cancer and New Potentially Synergistic Approaches with CDK Inhibition of the Retinoblastoma Protein and CAR T-Cell Immunotherapy. Journal of Innovations in Medical Research. 2, 11 (Nov. 2023), 24–27.